Development of health and welfare technologies is the theme that focuses on how digital solutions can be identified, created and tested. Examples of important questions that might be raised in this theme could be:

  • how can user and payer input can be better integrated in the development process?
  • how can outcomes that matter be prioritized during development?
  • how are the new requirements in the Medical Devices Regulation affecting development?


The process of putting a health and welfare technology into effect and operating in the environment it was intended for is the realisation of all development efforts. It is also a process often defined by complications and resistance. This theme aims to explore such questions as:

  • What are the enabling factors for successful implementation of health and welfare technologies?
  • What is the appropriate scale and timeframe for implementation of technologies in inexperienced environments?
  • How can resistance from personnel and other users be reduced when adjusting to new technologies?

Evaluating utility

Development and implementation achieved. But how useful and beneficial is the technology once operating? Is it profitable for the users or payers? This theme aims to discuss the utility of health and welfare technologies from different stakeholders’ perspectives. Examples of relevant questions for this theme might include:

  • How can the outcomes that matter for users and payers be measured in a reliable and valid manner?
  • How can profitability of a technology be measured over a lifecycle perspective?
  • How can we reconcile differences that arise in stakeholders’ perceptions of a technology’s benefits?


Both public and private sector purchasers use structured processes to obtain health and welfare technologies that best meet their needs, at the best possible price. But formulating and meeting specification requirements and evaluating incoming bids are tasks that present unique challenges. This theme discusses questions such as:

  • How can requirements regarding evidence for a technology’s effectiveness be best formulated and evaluated?
  • How do co-creation and co-development processes influence procurement processes?
  • What stakeholders and/or competencies should be represented when formulating requirements and evaluating bids?

Financing and reimbursement

Purchasers need to adequately finance new health and welfare technologies, sometimes with significant start-up costs. Developers must be reimbursed in a manner that promotes sustainable technology development. But these technologies have in some cases demonstrated the deficiencies or inapplicability of existing financing and reimbursement models. This theme discusses the methods by which stakeholders “show each other the money”. Such questions that might arise include:

  • How can reimbursement more accurately reflect achievement of outcomes that matter for different stakeholders?
  • What hybrid models might be optimal for financing technology purchases among users, caregiving organisations, and other parties?
  • What current or future payment or reimbursement models most likely to drive health and welfare technology development?
To top